(Delayed Data from OTC)
$0.37 USD
0.37
2,315
+0.01 (2.65%)
Updated Jun 7, 2024 12:14 PM ET
Zacks Rank:
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.08% |
| 2 | Buy | 17.91% |
| 3 | Hold | 9.44% |
| 4 | Sell | 5.10% |
| 5 | Strong Sell | 2.55% |
| S&P | 500 | 11.04% |
Zacks Rank Education - Learn about the Zacks Rank
Zacks Rank Home - Zacks Rank resources in one place
Zacks Premium - The only way to fully access the Zacks Rank
Style Scores:
The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.
| Value Score | A |
|---|---|
| Growth Score | A |
| Momentum Score | A |
| VGM Score | A |
Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.
Zacks Style Scores Education - Learn more about the Zacks Style Scores
NAValue | NAGrowth | NAMomentum | NAVGM
Industry Rank:
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
Bottom 41% (146 out of 248)
Industry: Medical - Generic Drugs
View All Zacks #1 Ranked Stocks
Quote Overview
Stock Activity
- Open
- 0.37
- Day Low
- 0.37
- Day High
- 0.38
- 52 Wk Low
- 0.20
- 52 Wk High
- 4.06
- 20 Day Avg Vol
- 24,451
- Market Cap
- 2.48 M
- Dividend
- 0.00 ( 0.00%)
- Beta
- 1.23
Key Earnings Data
- Earnings ESP
Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.
The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest.
Visit the Earnings ESP Center
See the Full List of Stocks To Beat Earnings
- NA
- Most Accurate Est
- NA
- Current Qtr Est
- NA
- Current Yr Est
- NA
- Exp Earnings Date
This is an estimated date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.
- 8/14/24
- Prior Year EPS
- -9.84
- Exp EPS Growth (3-5yr)
NA
- Forward PE
- NA
- PEG Ratio
- NA
Medical»Medical - Generic Drugs
Research Report for AGRX
Snapshot
News for AGRX
- Zacks News
- Earnings
- Other News
